Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

13 trials with published results (19%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.5%

3 terminated out of 67 trials

Success Rate

93.2%

+6.7% vs benchmark

Late-Stage Pipeline

13%

9 trials in Phase 3/4

Results Transparency

32%

13 of 41 completed with results

Key Signals

13 with results93% success

Data Visualizations

Phase Distribution

53Total
Not Applicable (25)
Early P 1 (2)
P 1 (15)
P 2 (2)
P 3 (4)
P 4 (5)

Trial Status

Completed41
Unknown14
Recruiting7
Terminated3
Withdrawn1
Active Not Recruiting1

Trial Success Rate

93.2%

Benchmark: 86.5%

Based on 41 completed trials

Clinical Trials (67)

Showing 20 of 20 trials
NCT03498001Not ApplicableCompletedPrimary

Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging

NCT05028140Phase 3RecruitingPrimary

Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus

NCT07167004Not ApplicableRecruiting

The GRoceries Aimed at Increasing Nutrition Study

NCT06049420Not ApplicableRecruiting

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

NCT06224803Not ApplicableCompletedPrimary

Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes

NCT04461405Not ApplicableCompletedPrimary

INTEGRATE-D: A Pilot Test to Support Integration of Medical and Psychosocial Care for People With Type II Diabetes

NCT02637609CompletedPrimary

Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst Scaling

NCT02637622CompletedPrimary

Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment

NCT04286555Not ApplicableCompleted

Dietary Approaches to Stop Hypertension for Diabetes

NCT05708859Phase 4RecruitingPrimary

Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

NCT06387433Not ApplicableActive Not RecruitingPrimary

Effectiveness of an mHealth Mobile App

NCT06385626Not ApplicableRecruitingPrimary

The Effects of Raspberry Leaf Tea on Blood Glucose Control

NCT05176210Phase 1RecruitingPrimary

Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects

NCT05741437Phase 1CompletedPrimary

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378

NCT01927562Not ApplicableCompletedPrimary

Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 Diabetes

NCT06245252Not ApplicableUnknownPrimary

Passive Stretching Versus Electrical Stimulation on Glucose Level, in Elderly With Type II Diabetes

NCT05881213Phase 1CompletedPrimary

Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults

NCT05878587Not ApplicableCompleted

Burger Allen Exercises in Knee OA With Type II Diabetes

NCT02947620Phase 3CompletedPrimary

Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)

NCT04893135Not ApplicableCompletedPrimary

Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Activity on the "Receptor Activator of Nuclear Factor-kappa B Ligand / Osteoprotégérine (RANKL / OPG) System in Patients Living With Type II Diabetes

Scroll to load more

Research Network

Activity Timeline